Jorge A. Carrasquillo
0000-0002-8513-5734
Publication & Citation Trends
Publications
0 total
Erratum: Phase II Study of 177Lu-DOTATATE for Progressive Metastatic Pheochromocytomas and Paragangliomas: Interim Analysis of Efficacy, Safety, and Biomarkers.
Cited by 1
Semantic Scholar
Development and validation of pan-cancer lesion segmentation AI-model for whole-body 18F-FDG PET/CT in diverse clinical cohorts
Cited by 1
Semantic Scholar
Phase II Study of 177Lu-DOTATATE for Progressive Metastatic Pheochromocytomas and Paragangliomas: Interim Analysis of Efficacy, Safety, and Biomarkers.
Cited by 7
Semantic Scholar
Effect of absorbed dose on toxicity and tumor response of Lu-177-DOTATATE with olaparib in gastroenteropancreatic neuroendocrine patients: preliminary results
Cited by 0
Semantic Scholar
DNA damage repair mutational status's effect on Lu-177-DOTATATE in combination with olaparib in metastatic SSTR+ GI neuroendocrine tumor: preliminary results
Cited by 0
Semantic Scholar
An automated pheochromocytoma and paraganglioma lesion segmentation AI-model at whole-body 68Ga- DOTATATE PET/CT OA
Cited by 6
Semantic Scholar
Diagnostic performance of [68Ga]DOTATATE PET/CT, [18F]FDG PET/CT, MRI of the spine, and whole-body diagnostic CT and MRI in the detection of spinal bone metastases associated with pheochromocytoma and paraganglioma OA
Cited by 14
Semantic Scholar
Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement
Cited by 68
Semantic Scholar
Research Topics
Radiopharmaceutical Chemistry and Applications
(203)
Monoclonal and Polyclonal Antibodies Research
(122)
Medical Imaging Techniques and Applications
(62)
Adrenal and Paraganglionic Tumors
(57)
Medical Imaging and Pathology Studies
(45)
Affiliations
United States Nuclear Regulatory Commission
Fundación Juan March
Fox Chase Cancer Center
National Institutes of Health
Beth Israel Deaconess Medical Center